Target intelligence / Profile preview

RNA, U2 small nuclear 65, pseudogene (RNU2-65P)

Target: RNU2-65P
Molecular classification: Other, Pseudogene, Small nuclear RNA (snRNA)

Overview

RNU2-65P (RNA, U2 small nuclear 65, pseudogene) is classified as a pseudogene of the U2 small nuclear RNA family and does not encode a functional RNA or protein[1][2][4]. It is listed as a pseudogene in major genomic databases (e.g., NCBI Gene: 106480226, Ensembl: ENSG00000222094) and is not known to be transcribed into a biologically active molecule[2][4]. Pseudogenes such as RNU2-65P are generally non-functional remnants of genes and are not considered therapeutic targets or associated with disease roles or drug interactions[4].

Other names: RNU2-65P

Beyond the preview

Go deeper on RNA, U2 small nuclear 65, pseudogene (RNU2-65P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 65, pseudogene (RNU2-65P).

Explore the full profile